USPTO serial 79268101
ZELDA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- STRUCK, ROBERT J
- Law office
- TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ZELDA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical cannabis and derivatives thereof; preparations for medical purposes derived from cannabis; therapeutic agents (medical); therapeutic creams (medical); therapeutic drugs (medical); natural healthcare preparations (medicaments); natural oils (medicinal); natural pharmaceutical products; pharmaceutical products derived from natural sources; pharmaceutical preparations; pharmaceutical preparations for human use; medical preparations; pharmaceutical preparations for health care; pharmaceutical preparations for nasal use; pharmaceutical preparations for oral use; pharmaceutical preparations for topical use; pharmaceutical preparations and substances for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cognitive disorders, alzheimer's, depression, autism and post-traumatic stress disorder; pain killers (pharmaceuticals); pharmaceutical preparations in the form of foams, gels, emulsions, elixirs, lotions, ointments, tinctures, creams, liquids, oils, lozenges, tablets, capsules, sprays and skin patches; analgesic preparations; antibacterial preparations; medical products; medicinal plants and herbs; medicinal oils; herbal preparations for medical purposes; plant extracts for medical use; plant extracts for pharmaceutical use; preparations for medical purposes | ACTIVE | — |
| 042 | Clinical trials; project management and planning of clinical trials; conducting clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; research and development of medicinal marijuana and cannabis products; medical research; medical research (scientific research for medical purposes); scientific research; research relating to science; provision of medical research services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 10, 2022 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 24, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 24, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 24, 2021 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 24, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 20, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 3, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 3, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 2, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 3, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 7, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 3, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 5, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 4, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 4, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 20, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 8, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 2, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 26, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |